BACKGROUND: The Medtronic Sprint Fidelis defibrillator lead is prone to fracture and was
recalled in 2007 after 665 failures and five reported deaths. Approximately 150,000 patients …

The clinical benefits of pacemakers and implantable cardioverter defibrillators (ICDs) have
been well-established by numerous scientific studies. 1–23 Millions of devices have been …

Background—Despite the positive effect on mortality in selected patients, implantable
cardioverter-defibrillator therapy is also associated with potential malfunction of the …

Aims Implantable cardioverter defibrillator (ICD) technology has become more complex,
particularly with respect to biventricular resynchronization devices. The incidence of …

BACKGROUND: Recent attention has been focused on the performance of high-voltage
implantable cardioverter-defibrillator (ICD) leads. Lead-related adverse events can be …

Although the use of implantable cardioverter defibrillator (ICD) therapy has increased over
the last decades, the reporting of ICD lead performance is inadequate. So far, there is …

Background: Defibrillator implanters have adopted different approaches to managing
failures of multicomponent implanted cardioverter defibrillator (ICD) leads. Although recent …

Cardiac function management devices, including implantable pacemakers and implantable
defibrillators, include at least 1 cardiac lead having an electrode for making contact with a …

En el presente artículo se revisan las novedades más relevantes relacionadas con la
arritmología clínica y la electrofisiología cardiaca intervencionista que han sido publicadas …

Implantable cardioverter defibrillators (ICDs) have become the standard of care for the
prevention of sudden cardiac death and for the management of ventricular arrhythmias. In …